FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 328:1134-1135 April 15, 1993 Number 15 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

(Clinical and Experimental Psychiatry. Monograph No. 6.) Edited by Jean-Pierre Lindenmayer and Stanley R. Kay. 299 pp., illustrated. New York, Brunner/Mazel, 1992. $41.95. ISBN 0-87630-654-7.

Research on schizophrenia is experiencing a growth spurt at the moment. Several areas, such as epidemiology and neuropsychology, are undergoing a radical overhaul. Others, such as structural imaging and neuropathology, continue to produce new findings. As with the rest of neuroscience, molecular biology and neurochemistry are the fastest-growing fields. The dopamine hypothesis of schizophrenia, which has been looking rather shaky for some time now, has effectively been toppled in its classic form, and the search is on for the missing neurochemical link.

This book charts some, although not all, of these developments. Edited by faculty members of the Albert Einstein . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.